In summary, this study indicates that ALDH2 gene polymorphisms may be a significant risk factor for CAD in patients with AF, and ALDH2 gene mutations (GA + AA) may diminish the lipid‐lowering efficacy of statins. Here, ALDH2 is linked to coronary artery disorder.